BioCentury | Nov 13, 2014
Cover Story

Boosting adjuvants

...agonist Not applicable Alba Therapeutics Corp. Preclinical MAS-1 Oil-and-water nanoparticle emulsion MER4101, an influenza vaccine Mercia Pharma Inc....
BioCentury | May 16, 2013
Distillery Therapeutics

Indication: Neurology

...studies in aged mouse AD models and preclinical development of the vaccine candidate. Researchers at Mercia Pharma Inc....
...testing or earlier development. SciBX 6(19); doi:10.1038/scibx.2013.472 Published online May 16, 2013 Patents filed by Mercia Pharma...
BioCentury | May 9, 2013
Targets & Mechanisms

AD vaccine redux

...Researchers at Harvard Medical School have teamed up with vaccine maker Mercia Pharma Inc. to design a next-generation...
...Mass. Intellect Neurosciences Inc. (OTCBB:ILNS), New York, N.Y. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Mercia Pharma Inc....
...Intellect Neurosciences Inc. (OTCBB:ILNS) RV-01 Four-amino-acid amino-terminal fragment of Ab conjugated to tetanus toxoid Preclinical Mercia Pharma Inc....
BioCentury | May 28, 2007
Clinical News

Cel-Sci preclinical data

...significantly more anti-H5 antibodies than controls (p<=0.01). MAS-1, a water-in-oil adjuvant delivery system, is from Mercia Pharma Inc....
Items per page:
1 - 4 of 4
BioCentury | Nov 13, 2014
Cover Story

Boosting adjuvants

...agonist Not applicable Alba Therapeutics Corp. Preclinical MAS-1 Oil-and-water nanoparticle emulsion MER4101, an influenza vaccine Mercia Pharma Inc....
BioCentury | May 16, 2013
Distillery Therapeutics

Indication: Neurology

...studies in aged mouse AD models and preclinical development of the vaccine candidate. Researchers at Mercia Pharma Inc....
...testing or earlier development. SciBX 6(19); doi:10.1038/scibx.2013.472 Published online May 16, 2013 Patents filed by Mercia Pharma...
BioCentury | May 9, 2013
Targets & Mechanisms

AD vaccine redux

...Researchers at Harvard Medical School have teamed up with vaccine maker Mercia Pharma Inc. to design a next-generation...
...Mass. Intellect Neurosciences Inc. (OTCBB:ILNS), New York, N.Y. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Mercia Pharma Inc....
...Intellect Neurosciences Inc. (OTCBB:ILNS) RV-01 Four-amino-acid amino-terminal fragment of Ab conjugated to tetanus toxoid Preclinical Mercia Pharma Inc....
BioCentury | May 28, 2007
Clinical News

Cel-Sci preclinical data

...significantly more anti-H5 antibodies than controls (p<=0.01). MAS-1, a water-in-oil adjuvant delivery system, is from Mercia Pharma Inc....
Items per page:
1 - 4 of 4